KKR to Buy Majority Stake in India's HCG

KKR to Buy Majority Stake in India’s HCG for $400 Million
KKR & Co Inc. is set to acquire a majority stake in India’s Healthcare Global Enterprises Ltd. from CVC Capital Partners at a deal valued at $400 million, making the private equity firm the largest shareholder and sole operator of the Indian cancer-care chain.
KKR to acquire stake in India-based Healthcare Global Enterprises for $400m
US-based investment company KKR has agreed to acquire a stake of up to 54% in Healthcare Global Enterprises (HCG), an oncology hospital chain in India, for $400m. KKR will acquire the stake in HCG from global private markets manager CVC Asia V at a rate of Rs445 ($5.
KKR Clinches $400 Million Deal To Take Controlling Stake In India's Cancer Hospital Chain HCG: Details
KKR & CVC Asia V reach definitive agreements to become the largest shareholder in HCG for $400M, with SEBI's Takeover Regulations allowing KKR to acquire up to 77% ownership. Founder will become Non-Executive Chairman as KKR strengthens its focus on India's healthcare sector.
KKR to acquire majority stake in India-based oncology hospital chain HCG for $400m
KKR has agreed to acquire a majority stake in Healthcare Global Enterprises, an India-based oncology hospital chain, for $400 million. The seller is CVC Capital Partners. Dr. BS Ajaikumar, founder of HCG, will take on the role of non-executive chairman.
KKR to Acquire Controlling Stake in Indian Hospital Operator for $400 Million
KKR has agreed to buy a controlling stake in Indian hospital operator HealthCare Global Enterprises for $400 million, adding to its recent investments in the country's healthcare industry.
KKR acquires controlling stake in Healthcare Global for $400M
KKR (KKR) and Healthcare Global Enterprises announced the signing of definitive agreements with CVC under which funds managed by KKR will
Healthcare Global Enterprises Announces Strategic Investment by KKR Worth $400 Million
As part of the deal, KKR will purchase up to 54 per cent of HCG's equity from CVC Asia V at a price of INR 445 per share.
KKR to acquire control of HealthCare Global in $400 million deal
KKR said it has agreed to acquire a controlling stake in cancer treatment chain HealthCare Global Enterprises Ltd (HCG) from fellow private equity firm CVC for ₹445 per share, amounting to around $400 million.

KKR, Perpetual

KKR's Options: A Look at What the Big Money is Thinking
The general mood among these heavyweight investors is divided, with 52% leaning bullish and 23% bearish. Among these notable ...
KKR Real Estate Finance: Discount To Book Value Could Tighten Further
Discover why KKR Real Estate Finance offers value with a 9% dividend yield, 24% discount to book value, and growth-focused strategies for 2025.
British Landlord Assura Turns Down KKR’s $2 Billion Takeover Bid
The board of Assura has rejected KKR’s fourth offer to acquire the British healthcare landlord in a deal that would have ...
KKR Lifts Stake in Japan's Fuji Soft, Ending Bidding War With Bain
KKR first launched its bid in August last year but Bain countered higher in October and had the backing of Fuji Soft's ...
KKR remains unshaken and determined despite Gautam Gambhir's exit, says Head of Talent Scouting | Exclusive
Biju George moved from his role as the fielding coach for Delhi Capitals and was appointed as the Head of Talent Scouting for ...
HCG shares up as KKR set to steer the ship
Healthcare Global Enterprises (HCG) rose 2.83% to Rs 514.15 after the company said KKR, a prominent global investment firm, will acquire a controlling stake in oncology hospital chain.
KKR Prepares Sale of BMC Helix at $2 Billion Value
KKR & Co. is preparing to sell BMC Helix in a deal that could value the information technology management company at about $2 ...
KKR & Co. Inc. stock outperforms competitors despite losses on the day
Shares of KKR & Co. Inc. KKR shed 1.73% to $132.22 Friday, on what proved to be an all-around dismal trading session for the ...